Ovid Therapeutics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Ovid Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $5.80. The average 1-year stock price forecast is 114.81% higher than the current stock price, while the lowest is $4.00 (+48.15%) and the highest is $9.00 (+233.33%).

Price Target: $5.80 (+114.81%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$4.00	$5.80	$5.00	$9.00
Change	+48.15%	+114.81%	+85.19%	+233.33%

Analyst Ratings

The average analyst rating for Ovid Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jul '26	Aug '26
Strong Buy	11	11	10	10	10	10
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Boobalan Pachaiyappan Roth MKM	Roth MKM	Buy Maintains $8	Buy	Maintains	$8	+196.30%	Sep 3, 2026
Francois Brisebois LifeSci Capital	LifeSci Capital	Buy Reiterates $5	Buy	Reiterates	$5	+85.19%	Aug 14, 2026
Kostas Biliouris Oppenheimer	Oppenheimer	Buy Reiterates $9	Buy	Reiterates	$9	+233.33%	Aug 14, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $7	Buy	Maintains	$7	+159.26%	Aug 14, 2026
Myles Minter William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Aug 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

828.67K

from 7.25M

-88.57%

from 7.25M

Revenue Next Year

223.30K

from 828.67K

-73.05%

from 828.67K

EPS This Year

-0.38

from -0.23

EPS Next Year

-0.40

from -0.38

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	208.38M	1.50M	392.00K	566.00K	7.25M	828.67K
Revenue Growth	1,551.57%	-99.28%	-73.91%	44.39%	1,181.27%	-88.57%
Operating Income	124.21M	-55.55M	-57.58M	-58.39M	-42.44M	-70.68M
Net Income	122.83M	-54.17M	-52.34M	-26.43M	-17.41M	-68.49M
EPS	-	-	-	-	-0.23	-0.38
Free Cash Flow	75.60M	-36.24M	-25.89M	-29.90M	-25.64M	-72.25M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.6M
Avg	828,670
Low	700,000

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-78.2%
Avg	-88.6%
Low	-90.3%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.35
Avg	-0.38
Low	-0.41

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-